21204267|t|Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
21204267|a|Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset syndrome characterized by progressive degeneration of specific muscles. OPMD is caused by extension of a polyalanine tract in poly(A) binding protein nuclear 1 (PABPN1). Insoluble nuclear inclusions form in diseased muscles. We have generated a Drosophila model of OPMD that recapitulates the features of the disorder. Here, we show that the antiprion drugs 6-aminophenanthridine (6AP) and guanabenz acetate (GA), which prevent formation of amyloid fibers by prion proteins in cell models, alleviate OPMD phenotypes in Drosophila, including muscle degeneration and nuclear inclusion formation. The large ribosomal RNA and its activity in protein folding were recently identified as a specific cellular target of 6AP and GA. We show that deletions of the ribosomal DNA locus reduce OPMD phenotypes and act synergistically with sub-effective doses of 6AP. In a complementary approach, we demonstrate that ribosomal RNA accelerates in vitro fibril formation of PABPN1 N-terminal domain. These results reveal the conserved role of ribosomal RNA in different protein aggregation disorders and identify 6AP and GA as general anti-aggregation molecules.
21204267	0	9	Antiprion	Chemical	-
21204267	16	37	6-aminophenanthridine	Chemical	MESH:C549408
21204267	42	51	guanabenz	Chemical	MESH:D006143
21204267	59	65	PABPN1	Gene	35788
21204267	66	74	toxicity	Disease	MESH:D064420
21204267	94	128	oculopharyngeal muscular dystrophy	Disease	MESH:D039141
21204267	130	164	Oculopharyngeal muscular dystrophy	Disease	MESH:D039141
21204267	166	170	OPMD	Disease	MESH:D039141
21204267	253	260	muscles	Disease	MESH:D019042
21204267	262	266	OPMD	Disease	MESH:D039141
21204267	295	306	polyalanine	Chemical	MESH:C019529
21204267	316	349	poly(A) binding protein nuclear 1	Gene	35788
21204267	351	357	PABPN1	Gene	35788
21204267	406	413	muscles	Disease	MESH:D019042
21204267	435	445	Drosophila	Species	7227
21204267	455	459	OPMD	Disease	MESH:D039141
21204267	532	541	antiprion	Chemical	-
21204267	548	569	6-aminophenanthridine	Chemical	MESH:C549408
21204267	571	574	6AP	Chemical	MESH:C549408
21204267	580	597	guanabenz acetate	Chemical	MESH:D006143
21204267	599	601	GA	Chemical	MESH:D006143
21204267	631	645	amyloid fibers	Disease	MESH:C000718787
21204267	690	694	OPMD	Disease	MESH:D039141
21204267	709	719	Drosophila	Species	7227
21204267	731	750	muscle degeneration	Disease	MESH:D009410
21204267	902	905	6AP	Chemical	MESH:C549408
21204267	910	912	GA	Chemical	MESH:D006143
21204267	971	975	OPMD	Disease	MESH:D039141
21204267	1039	1042	6AP	Chemical	MESH:C549408
21204267	1148	1154	PABPN1	Gene	35788
21204267	1244	1273	protein aggregation disorders	Disease	MESH:D066263
21204267	1287	1290	6AP	Chemical	MESH:C549408
21204267	1295	1297	GA	Chemical	MESH:D006143
21204267	Positive_Correlation	MESH:C019529	MESH:D039141
21204267	Negative_Correlation	MESH:D006143	MESH:D064420
21204267	Negative_Correlation	MESH:C549408	MESH:D064420
21204267	Negative_Correlation	MESH:D006143	MESH:D039141
21204267	Negative_Correlation	MESH:D006143	MESH:C000718787
21204267	Association	MESH:C019529	35788
21204267	Association	MESH:D064420	35788
21204267	Negative_Correlation	MESH:C549408	MESH:D039141
21204267	Negative_Correlation	MESH:D006143	35788
21204267	Association	MESH:D039141	35788
21204267	Negative_Correlation	MESH:C549408	MESH:C000718787
21204267	Negative_Correlation	MESH:C549408	MESH:D066263
21204267	Negative_Correlation	MESH:D006143	MESH:D009410
21204267	Negative_Correlation	MESH:C549408	35788
21204267	Negative_Correlation	MESH:C549408	MESH:D009410

